FDA approves Cochlear Nucleus Implants for unilateral hearing loss/single-sided deafness
/PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of...
Source: prnewswire.com